News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
418,093 Results
Type
Article (23221)
Company Profile (145)
Press Release (394727)
Section
Business (131140)
Career Advice (909)
Deals (22928)
Drug Delivery (91)
Drug Development (60676)
Employer Resources (81)
FDA (9497)
Job Trends (9422)
News (227318)
Policy (20274)
Tag
Academia (1130)
Alliances (30650)
Alzheimer's disease (836)
Approvals (9459)
Artificial intelligence (104)
Bankruptcy (202)
Best Places to Work (7161)
Biosimilars (69)
Biotechnology (66)
Breast cancer (87)
Cancer (817)
Cardiovascular disease (73)
Career advice (738)
Cell therapy (138)
Clinical research (49616)
Collaboration (265)
Compensation (101)
COVID-19 (1291)
Data (848)
Diabetes (111)
Diagnostics (2841)
Drug pricing (91)
Earnings (56390)
Employer resources (75)
Events (73060)
Executive appointments (216)
FDA (9837)
Funding (205)
Gene therapy (114)
GLP-1 (511)
Government (2371)
Healthcare (9235)
Infectious disease (1351)
Inflammatory bowel disease (82)
Interviews (124)
IPO (10244)
Job creations (2580)
Job search strategy (673)
Layoffs (271)
Legal (4653)
Lung cancer (146)
Manufacturing (142)
Medical device (4804)
Medtech (4807)
Mergers & acquisitions (12751)
Metabolic disorders (344)
Neuroscience (1042)
NextGen Class of 2024 (3192)
Non-profit (1633)
Northern California (963)
Obesity (215)
Opinion (180)
Patents (74)
People (36741)
Pharmaceutical (76)
Phase I (14925)
Phase II (21339)
Phase III (17137)
Pipeline (356)
Policy (69)
Postmarket research (1927)
Preclinical (5715)
Radiopharmaceuticals (185)
Rare diseases (157)
Real estate (3538)
Regulatory (14097)
Research institute (1178)
Resumes & cover letters (148)
Southern California (884)
Startups (2199)
United States (8584)
Vaccines (282)
Weight loss (187)
Date
Last 7 days (701)
Last 30 days (2659)
Last 365 days (24139)
2024 (21943)
2023 (26256)
2022 (33509)
2021 (34903)
2020 (32714)
2019 (26563)
2018 (20462)
2017 (21282)
2016 (20272)
2015 (23858)
2014 (18786)
2013 (15384)
2012 (16573)
2011 (17209)
2010 (15682)
Location
Africa (445)
Arizona (78)
Asia (27620)
Australia (3931)
California (2146)
Canada (911)
China (179)
Colorado (99)
Connecticut (105)
Europe (59830)
Florida (268)
Illinois (200)
Indiana (136)
Maryland (328)
Massachusetts (1813)
Michigan (66)
Minnesota (142)
New Jersey (680)
New York (634)
North Carolina (449)
Northern California (963)
Ohio (80)
Pennsylvania (510)
South America (669)
Southern California (884)
Texas (282)
Washington State (243)
418,093 Results for "purdue pharma l p".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Purdue Pharma L.P. Awards Grant for Investigator-initiated Research to Examine Opioid Overdose Reversal Using Nalmefene HCl Injection
Purdue Pharma L.P. (“Purdue”) announced today that the Company has awarded an investigator-initiated research (IIR) grant to a team of researchers at The University of New Mexico (UNM) for the evaluation of nalmefene hydrochloride (HCl) injection 2mg/2mL (1mg/1mL) in the emergency department setting.
March 27, 2024
·
7 min read
Deals
Agile Therapeutics Inc. Announces Definitive Merger Agreement with Insud Pharma, S.L.
Agile Therapeutics, Inc. today announced that it has entered into a definitive merger agreement (“Merger Agreement”) with Insud Pharma, S.L.
June 26, 2024
·
10 min read
Pharm Country
Purdue Pharma L.P. to Provide Funding Opportunities for Investigator-Initiated Research to Examine Opioid Overdose Reversal Using Nalmefene HCl Injection
Purdue Pharma L.P. is accepting proposals for investigator-initiated research (IIR) to examine the outcomes associated with the use of Nalmefene Hydrochloride injection, 2mg/2mL (1mg/1mL).
March 28, 2023
·
6 min read
Pharm Country
FDA Accepts Filing of New Drug Application for Nalmefene Auto-injector for the Treatment of Known or Suspected Opioid Overdose
Purdue Pharma L.P. (“Purdue”) announced today that FDA has accepted for filing the company’s New Drug Application (NDA) for the auto-injector delivery form of nalmefene hydrochloride injection*.
April 8, 2024
·
6 min read
Editorial
Pharma’s Q3 Was a Rollercoaster Ride. Let’s Do It Again Next Quarter
Big Pharma had plenty of drama to keep journalists busy this quarter, which painted an accurate portrait of the wild and wonderful world of biopharma.
November 15, 2024
·
3 min read
·
Annalee Armstrong
Business
Jérôme Vailland Joins 4P-Pharma as Chief Financial Officer
4P-Pharma, a clinical-stage biotech based in Lille dedicated to developing curative therapies for serious untreated diseases, is thrilled to announce the appointment of Jérôme Vailland as Chief Financial Officer for 4P-Pharma and its subsidiaries.
March 14, 2024
·
3 min read
Business
Agile Therapeutics Inc. Announces Completion of Acquisition by Insud Pharma, S.L.
August 26, 2024
·
5 min read
Bio NC
Verona Pharma Announces $650 Million Strategic Financing with Oaktree and OMERS
Verona Pharma plc, announces it and its wholly-owned subsidiary, Verona Pharma, Inc., have entered into strategic financing agreements providing access to up to $650 million from funds managed by Oaktree Capital Management, L.P. and OMERS Life Sciences.
May 9, 2024
·
10 min read
Press Releases
Lantern Pharma to Report Third Quarter 2024 Operating & Financial Results on November 7th, 2024 at 4:30 p.m. ET
October 31, 2024
·
5 min read
4P-Pharma Announces Total Capital of €15 Million Successfully Secured in Second Closing
4P-Pharma, a Lille-based clinical-stage startup studio focused on developing curative therapies for untreated serious diseases, announces that it has successfully secured a total capital of €15 million in its second closing with participation from private investors.
April 29, 2024
·
3 min read
1 of 41,810
Next
